Mudit brings two decades of entrepreneurial experiences in medical device industry across R&D, business development, company formation, venture capital, and a global perspective to healthcare based on his experiences in USA, Ireland, and India. Mudit has a unique blend of experiences as a private venture capitalist at Synergy Life Science Partners, and as a strategic investor with Johnson and Johnson Development Corporation (JJDC). Mudit serves on boards of Neurotronik, Ltd., Inspire Medical Systems (NYSE: INSP), Noctrix, Ltd., NuXcel, Ltd. And ShiraTronics, Inc.  Most recently, as a General Partner with Synergy Life Science Partners, Mudit delivered top quartile performance.

Earlier in his career, Mudit held operational roles at Guidant Corporation’s Cardiac Rhythm Management Division and in petrochemical industry in India. Mudit played an important role in product  development for start-ups like Epicor, Inc. (acquired: St. Jude Medical), and Cardiac Pathways Corporation (acquired: Boston Scientific). Mudit holds eight issued patents and has published numerous articles in peer reviewed publications.

Mudit currently serves on the Board of Visitors at Duke University’s Graduate School, John Hopkins University Coulter Program Oversight Board, and on the  board of One Heart Health, an organization dedicated to advancing remote monitoring technologies to identify and treat cardiac disease in children across the globe. Mudit also served as Chair of TiE LifeSciences, Silicon Valley from 2012-2014.

Mudit graduated with a B.E. in Electrical Engineering from Regional Engineering College, Nagpur, India (ranked first in his class). He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.

Lynn brings three decades of active implantable device experience in medical device innovation, R&D, manufacturing, clinical trials, and regulatory approvals to healthcare challenges. Lynn has a unique blend of experience in large medical device companies such as Guidant and Boston Scientific and small venture capital funded startups like Spinal Modulation, SacraMed, and ShiraTronics.

At Guidant, Lynn held leadership positions in Product Development and Research & Advanced Technologies and was a key driver of delivering pacemakers, implantable defibrillators and cardiac resynchronization device to the global market with revenues in excess $1B.

At Spinal Modulation, Lynn held the position of Chief Technology Officer and was a key driver of defining and delivering an innovative neurostimulation device for the management of chronic pain. Spinal Modulation was acquired by St Jude (Abbott) in a deal valued in excess of $500M.

Lynn holds over 20 US patents and has published numerous articles in peer reviewed publications.  Lynn graduated with a BS in Electrical Engineering from South Dakota School of Mines and Technology, an MS in Software Engineering from St Thomas University and advanced studies in Software Engineering at the University of Minnesota.